Skip to main content

Table 3 Comparison of retinal and choroidal thickness measurements using EDI-OCT in patients with SCD with and without retinopathy

From: Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study

  SCD with retinopathy
Mean µm ± standard deviation (median)
SCD without retinopathy
Mean µm ± standard deviation (median)
p value
Retinal thickness
 Central 253.00 ± 23.39 (256.00) 258.15 ± 19.40 (256.00) 0.665
 Superior parafovea 347.48 ± 30.20 (346.00) 343.16 ± 14.37 (344.00) 0.423
 Nasal parafovea 348.52 ± 22.39 (346.00) 344.06 ± 13.79 (343.00) 0.298
 Inferior parafovea 345.26 ± 19.94 (344.00) 341.94 ± 11.33 (341.50) 0.313
 Temporal parafovea 332.11 ± 18.60 (331.00) 330.17 ± 14.66 (329.00) 0.688
 Superior perifovea 323.26 ± 13.12 (320.00) 314.84 ± 12.49 (314.50) 0.029*
 Nasal perifovea 330.11 ± 18.58 (329.00) 323.94 ± 12.55 (325.00) 0.636
 Inferior perifovea 313.36 ± 17.04 (313.00) 307.26 ± 17.00 (303.50) 0.356
 Temporal perifovea 297.44 ± 11.97 (294.00) 291.06 ± 10.04 (289.00) 0.058
Choroidal thickness
 Fovea 237.50 ± 17.86 (235.50) 242.46 ± 22.85 (240.00) 0.391
 Temporal parafovea 230.45 ± 17.18 (230.00) 231.41 ± 22.93 (229.00) 0.854
 Nasal parafovea 224.40 ± 16.03 (225.00) 224.59 ± 19.09 (222.00) 0.979
 Temporal perifovea 228.70 ± 34.87 (214.00) 215.77 ± 27.40 (210.00) 0.108
 Nasal perifovea 202.80 ± 16.62 (199.00) 202.13 ± 18.18 (200.00) 0.953
  1. *p < 0.05 is significant